Reasons for choosing our testing services
ZHONGXI Testing has obtained inspection qualification certifications from multiple countries and regions worldwide. We possess a senior testing team and advanced testing methods, providing independent, impartial, and professional third-party verification services for global carbon projects.
Internationally recognized authority
Certified by multiple international standards such as CNAS, VCS, and GS, with reports universally applicable worldwide.
Global service capability
Covering 140+ countries and regions, it supports on-site detection and remote verification in multiple languages.
Professional experimental methods
Adopt standard experimental methods to ensure accurate and reliable data.
Advanced Pharmaceutical Residue Testing Services: Trace-Level Detection for Food Safety, Environmental Monitoring, and Regulatory Compliance
Pharmaceutical residues encompass a broad spectrum of parent drugs, active metabolites, and transformation products originating from veterinary medicines, human therapeutics, and agricultural applications. These compounds enter food chains and environmental compartments through livestock treatment, aquaculture practices, improper disposal, and wastewater discharge. Their persistence and biological activity raise concerns regarding antimicrobial resistance, endocrine disruption, allergic sensitization, and chronic low-dose exposure. Regulatory bodies worldwide, including the European Medicines Agency (EMA), the U.S. Food and Drug Administration (FDA), and the Codex Alimentarius Commission, establish maximum residue limits (MRLs) and withdrawal periods to protect public health. Consequently, pharmaceutical residue testing has become indispensable for market access, consumer protection, and environmental stewardship.
Why Clients Commission Pharmaceutical Residue Testing
Clients seek pharmaceutical residue testing for a range of interconnected objectives. Regulatory compliance requires that food commodities of animal origin — meat, milk, eggs, honey, and aquaculture products — contain residues below established MRLs before entering domestic or international trade. Export certification frequently demands analytical evidence to satisfy destination market requirements, particularly for jurisdictions with zero-tolerance policies toward certain compounds. Environmental monitoring programs assess the presence and fate of pharmaceuticals in surface water, groundwater, soil, and sediment, supporting ecological risk assessment and wastewater treatment optimization. Pharmaceutical manufacturing and quality control rely on residue analysis to verify cleaning validation, cross-contamination control, and effluent discharge compliance. Finally, research and forensic investigations utilize residue data to study pharmacokinetics, environmental persistence, and illicit drug use patterns through wastewater-based epidemiology.
Our Pharmaceutical Residue Testing Capabilities: From Routine Screening to Ultra-Trace Quantification
We provide comprehensive pharmaceutical residue testing services spanning veterinary drugs, human pharmaceuticals, and their metabolites. Our analytical portfolio includes, but is not limited to:
Antibiotics and antimicrobials — including beta-lactams (penicillins, cephalosporins), tetracyclines, sulfonamides, macrolides, aminoglycosides, quinolones, lincosamides, amphenicols (chloramphenicol), and nitrofurans (including their tissue-bound metabolites AOZ, AMOZ, AHD, and SEM).
Antiparasitic agents — including avermectins (ivermectin, abamectin), milbemycins, benzimidazoles (albendazole, fenbendazole), and coccidiostats (ionophores such as monensin, salinomycin, and lasalocid).
Hormones and growth promoters — including natural and synthetic steroids (estradiol, testosterone, progesterone), stilbenes (diethylstilbestrol), resorcylic acid lactones (zeranol), and beta-agonists (clenbuterol, ractopamine, salbutamol).
Non-steroidal anti-inflammatory drugs (NSAIDs) — including phenylbutazone, flunixin, diclofenac, and ketoprofen.
Human pharmaceuticals and emerging contaminants — including antidepressants, anticonvulsants, beta-blockers, lipid regulators, and contrast media in environmental matrices.
Illicit drugs and metabolites — supporting wastewater-based epidemiology and forensic applications.
Our laboratories employ LC-MS/MS (liquid chromatography-tandem mass spectrometry) for targeted quantification, LC-HRMS (high-resolution mass spectrometry) for suspect screening and non-targeted analysis, and GC-MS/MS for volatile and thermally stable analytes. These platforms enable ultra-trace detection at levels as low as 0.01–0.1 µg/kg (ppb) for most veterinary drug residues, and in selected matrices, detection limits extend into the low parts-per-trillion (ppt) range. For high-throughput screening, we also offer validated ELISA and lateral flow immunoassay methods, with presumptive positives confirmed by mass spectrometry.
Methodological Depth and Analytical Rigor
Our testing protocols are founded upon ISO/IEC 17025-accredited quality management systems, ensuring metrological traceability, reproducibility, and international acceptance. We perform rigorous matrix-specific method validation, evaluating selectivity, specificity, linearity, accuracy, precision, recovery, matrix effects, and stability for each analyte-matrix combination. Sample preparation strategies are optimized per commodity and include QuEChERS, solid-phase extraction (SPE), dispersive SPE (dSPE), immunoaffinity chromatography (IAC), pressurized liquid extraction (PLE), and enzymatic hydrolysis for tissue-bound residues.
Our mass spectrometry workflows utilize stable isotope-labeled internal standards (SIL-IS) and isotope dilution assays to achieve absolute quantification with recovery rates of 70–120% and relative standard deviations (RSDs) below 15%, consistent with EU Commission Regulation 2021/808 and FDA Center for Veterinary Medicine guidance. For multi-residue panels, we employ scheduled multiple reaction monitoring (sMRM) and ion mobility spectrometry (IMS) to resolve isobaric interferences and enhance confidence in identification. Where relevant, we also conduct metabolite profiling and transformation product identification to assess total residue burden and environmental fate.
Our Competitive Advantages in Pharmaceutical Residue Testing
1. Unmatched Breadth of Analyte Coverage: Our multi-residue methods encompass over 300 veterinary drugs and metabolites in a single analytical run, spanning all major drug classes and regulatory jurisdictions.
2. Ultra-High Sensitivity and Selectivity: Our LC-MS/MS and HRMS platforms achieve quantification limits that meet or exceed the most stringent global MRLs, including those for banned substances where zero tolerance applies and detection capability must reach 0.1 µg/kg or lower.
3. Complex Matrix Expertise: We have validated methods for challenging matrices including honey, royal jelly, aquaculture products, offal, urine, plasma, milk, eggs, feed, soil, sediment, and wastewater, where conventional approaches frequently fail due to matrix effects or low recovery.
4. Non-Targeted and Suspect Screening: Our HRMS workflows enable retrospective data mining, allowing clients to re-interrogate archived datasets for newly identified compounds of concern without re-analysis.
5. Rapid Turnaround and High Throughput: Standard turnaround is 5–7 business days, with expedited options available. Automated sample preparation and data processing pipelines ensure consistent, high-volume output without compromising analytical quality.
6. Expert Interpretation and Regulatory Support: Our team includes analytical chemists, pharmacologists, and regulatory specialists who provide not only analytical data but also risk-based interpretation, MRL compliance assessment, and guidance on withdrawal periods, trade disputes, and recall decisions.
7. Custom Method Development and Research Collaboration: For clients with novel matrices, emerging contaminants, or specialized research objectives, we offer bespoke method development, validation, and technology transfer services, including pharmacokinetic studies and environmental fate assessments.
Applications Across Industries
Our pharmaceutical residue testing services support a diverse range of clients, including food producers and processors, aquaculture operators, importers and exporters, regulatory agencies, pharmaceutical manufacturers, environmental consultancies, water utilities, and research institutions. Whether for routine compliance monitoring, export certification, cleaning validation, environmental risk assessment, or investigative research, we deliver data that is defensible, precise, and directly actionable for regulatory and scientific decisions.
Conclusion
Pharmaceutical residues represent a persistent challenge at the intersection of food safety, public health, and environmental sustainability. Reliable analytical detection is the foundation of every credible residue monitoring program and regulatory control framework. With our advanced instrumentation, comprehensive validation, and deep domain expertise, we empower clients to meet the most demanding compliance requirements, protect consumers and ecosystems, and maintain confidence across global supply chains. For pharmaceutical residue testing that achieves the highest standards of sensitivity, specificity, and reliability, our laboratory is your trusted analytical partner.